Upcoming events
ASGCT
Venue: Baltimore Convention Center, Baltimore, USA
Date:
May 07, 2024 -
May 11, 2024
The mission of American Society of Gene & Cell Therapy is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. The Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. ASGCT's annual meeting brings together more than 3,400 professionals including scientists, physicians, and patient advocates.
You can find TriLink at booth #634.
Schedule a meeting with us
Register Now
You can find TriLink at booth #634.
Schedule a meeting with us
Register Now
TIDES USA 2024
Venue: Hynes Convention Center, Boston, USA
Date:
May 14, 2024 -
May 17, 2024
Each year, the TIDES conference scientific agenda includes 150+ of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.
You can find TriLink at booth #507.
Featured Presentation
Date: May 15, 2024
Time: 12:35 PM ET
Title: mRNA chemical modification and the impact on protein translation
Featured Speaker:
Chunping Xu, PhD
Senior Director of Chemistry and R&D, TriLink BioTechnologies
Summary: Due to its inherent instability and immunostimulatory properties, the use of exogenous mRNA in therapeutic applications has previously been limited. The recent pandemic has accelerated the development of mRNA vaccines, including the integration of techniques to improve mRNA functions. One such technique is chemical modification, which can be incorporated throughout the mRNA sequence (from cap to tail) to modulate its translational activity and immunogenicity. In this presentation, we will discuss cap modification, base modification, tail modification, and their impacts on protein translation and immunogenicity.
Schedule a meeting with us
Register Now
You can find TriLink at booth #507.
Featured Presentation
Date: May 15, 2024
Time: 12:35 PM ET
Title: mRNA chemical modification and the impact on protein translation
Featured Speaker:
Chunping Xu, PhD
Senior Director of Chemistry and R&D, TriLink BioTechnologies
Summary: Due to its inherent instability and immunostimulatory properties, the use of exogenous mRNA in therapeutic applications has previously been limited. The recent pandemic has accelerated the development of mRNA vaccines, including the integration of techniques to improve mRNA functions. One such technique is chemical modification, which can be incorporated throughout the mRNA sequence (from cap to tail) to modulate its translational activity and immunogenicity. In this presentation, we will discuss cap modification, base modification, tail modification, and their impacts on protein translation and immunogenicity.
Schedule a meeting with us
Register Now
4th mRNA Based Therapeutics Summit USA
Venue: The Westin Boston Seaport District, Boston
Date:
Jul 29, 2024 -
Jul 31, 2024
Welcome to the World’s Largest Industry-Dedicated Gathering for mRNA Professionals. 2023 saw the Nobel Prize awarded to mRNA technology, reinvigorating the field and spurring a new wave of candidates entering the clinic. The industry has made tremendous strides in applying mRNA technology beyond COVID-19, and as mRNA unlocks the rare, infectious and oncological spaces, the 4th mRNA-Based Therapeutics Summit maintains its position as the world's most comprehensive, end-to-end industry-dedicated conference, bringing you exclusive scientific and strategic insights from the biggest players across indications and modalities.
Featured Presentation
Date: July 30, 2024
Time: 2:45 p.m. ET
Title: Mitigating risk through development and engineering runs when transitioning from preclinical to clinical manufacturing
Featured Speaker:
Evan Meyers
Associate Director of Process Development, TriLink BioTechnologies
Learning Objectives:
- Identifying common challenges with preclinical and clinical transitions in mRNA manufacturing
- Mitigating risk and streamlining mRNA manufacturing across phases through scale-up, process robustness, and reproducibility
- Case study | Leveraging insights from a process development and engineering run
Schedule a meeting with us
Register Now
Featured Presentation
Date: July 30, 2024
Time: 2:45 p.m. ET
Title: Mitigating risk through development and engineering runs when transitioning from preclinical to clinical manufacturing
Featured Speaker:
Evan Meyers
Associate Director of Process Development, TriLink BioTechnologies
Learning Objectives:
- Identifying common challenges with preclinical and clinical transitions in mRNA manufacturing
- Mitigating risk and streamlining mRNA manufacturing across phases through scale-up, process robustness, and reproducibility
- Case study | Leveraging insights from a process development and engineering run
Schedule a meeting with us
Register Now